|
1
|
SHNLSLNYC2604011
|
2739CASE = 27PLTS EZETIMIBE 10MG TABLETS 90CT (NDC 10135-0787-90) PO NO.XXXXXXXX E062085 E062086 E062087
|
MARLEX PHARMACEUTICALS,INC.
|
ORIENT PHARMA CO. LTD
|
2026-06-04
|
China Taiwan
|
3812 Kgs
|
2739 CAS
|
|
2
|
SHNLSLNYC2604008
|
S.L.A.C. 3228CASE = 33PLTS EZETIMIBE 10MG TABLETS 30CT (NDC 10135-0787-30) PO NO.XXXXXXXX E0620821 E0620831, E0620841 EZETIMIBE 10MG TABLETS 90CT (NDC 10135-0787-90) PO NO.XXXXXXXX E0620822 E0620832 E0620842
|
MARLEX PHARMACEUTICALS,INC.
|
ORIENT PHARMA CO. LTD
|
2026-05-27
|
China Taiwan
|
4428 Kgs
|
3228 CAS
|
|
3
|
SHNLSLNYC2604005
|
S.T.C. 3228CAS = 33PLTS EZETIMIBE 10MG TABLETS 30CT (NDC 10135-0787-30) PO NO.XXXXXXXX E0620791 E0620801, E0620811 EZETIMIBE 10MG TABLETS 90CT (NDC 10135-0787-90) PO NO.XXXXXXXX E0620792 E0620802 E0620812
|
MARLEX PHARMACEUTICALS,INC.
|
ORIENT PHARMA CO. LTD
|
2026-05-21
|
China Taiwan
|
4427 Kgs
|
3228 CAS
|
|
4
|
SHNLSLNYC2601009
|
CASE = PLTS EZETIMIBE MG TABLETS CT (NDC --) PO NO.MPO- E E E
|
MARLEX PHARMACEUTICALS,INC.
|
ORIENT PHARMA CO. LTD
|
2026-02-21
|
China Taiwan
|
3565 Kgs
|
2563 CAS
|
|
5
|
SHNLSLNYC2512004
|
CASE = PLTS EZETIMIBE MG TABLETS CT (NDC - - ) PO NO.MPO- E E E, E E
|
MARLEX PHARMACEUTICALS,INC.
|
ORIENT PHARMA CO. LTD
|
2026-01-16
|
China Taiwan
|
6279 Kgs
|
4507 CAS
|
|
6
|
SHNLSLNYC2511004
|
CASE = PLTS EZETIMIBE MG TABLETS CT (NDC - - ) PO NO.MPO- E E E, E E E E E E E
|
MARLEX PHARMACEUTICALS,INC.
|
ORIENT PHARMA CO. LTD
|
2025-12-17
|
China Taiwan
|
4863 Kgs
|
6547 CAS
|
|
7
|
SHNLSLNYC2510024
|
, CASE= PLTS EZETIMIBE MG TABLETS CT (NDC - - ) PO NO.MO- E EZETIMIBE MG TABLETS CT (NDC - - ), PO NO.MPO- E PO NO.MPO- E E E HS CODE. . EE E E E
|
MARLEX PHARMACEUTICALS,INC.
|
ORIENT PHARMA CO. LTD
|
2025-12-12
|
China Taiwan
|
5568 Kgs
|
6719 CAS
|
|
8
|
SHNLSLNYC2507009
|
PO NO.MPO- EZETIMIBE MG TABLETS CT (NDC - - ) E E E E, E E E E E E , CASES = PLTS
|
MARLEX PHARMACEUTICALS,INC.
|
ORIENT PHARMA CO. LTD
|
2025-08-25
|
China Taiwan
|
4546 Kgs
|
6110 CAS
|
|
9
|
PSEAPKNYC2550018
|
EZETIMIBE TABLETS USP, 10MG EZETIMIBE 10MG TABLETS 30CT (NDC 10135-0787-30) E061034 EZETIMIBE TABLETS USP, 10MG EZETIMIBE 10MG TABLETS 90CT (NDC 10135-0787-90) E062035 EZETIMIBE TABLETS USP, 10MG EZETIMIBE 10MG TABLETS 500CT (NDC 10135-0787-05) E061035 EZETIMIBE TABLETS USP, 10MG EZETIMIBE 10MG TAB, LETS 500CT (NDC 10135-0787-05) E062036 EZETIMIBE TABLETS USP, 10MG EZETIMIBE 10MG TABLETS 500CT (NDC 10135-0787-05) E062037 EZETIMIBE TABLETS USP, 10MG EZETIMIBE 10MG TABLETS 500CT (NDC 10135-0787-05) E062038 EZETIMIBE TABLETS USP, 10MG EZETIMIBE 10MG TABLETS 500CT (NDC 10135-0787-05) E062039 5051CTNS(35PLTS) HS CODE:3004.90 TEMP:+20DEGREE C
|
MARLEX PHARMACEUTICALS INC.
|
ORIENT PHARMA CO. LTD
|
2025-07-09
|
China Taiwan
|
5026 Kgs
|
5051 CTN
|
|
10
|
SAYIKONY25010248
|
EZETIMIBE 10MG TABLETS 500CT (NDC 10135-0787-05) HS CODE3004.90 23PLTS=4790CASES
|
MARLEX PHARMACEUTICALS INC.
|
ORIENT PHARMA CO. LTD
|
2025-03-26
|
China Taiwan
|
3566 Kgs
|
4790 CAS
|